Aussie medtech company ResApp Health (ResApp) recently announced news of its sale to Pfizer Australia, a wholly-owned subsidiary of global biopharmaceutical company Pfizer Inc. The proposed acquisition will mean that Pfizer will acquire 100% of the shares in ResApp (by way of a Scheme of Arrangement) for A$0.115...

In light of recent events, the Russian Federation issued a decree for a new methodology for compensating for patent infringement where a patentee originates from an unfriendly country.[1] While the decree does not preclude a patentee from seeking relief, it reduces the maximum relief available...

Translate »